81 related articles for article (PubMed ID: 1862205)
1. Treatment of age-associated memory impairment with guanfacine.
McEntee WJ; Crook TH; Jenkyn LR; Petrie W; Larrabee GJ; Coffey DJ
Psychopharmacol Bull; 1991; 27(1):41-6. PubMed ID: 1862205
[TBL] [Abstract][Full Text] [Related]
2. The effects of guanfacine on context processing abnormalities in schizotypal personality disorder.
McClure MM; Barch DM; Romero MJ; Minzenberg MJ; Triebwasser J; Harvey PD; Siever LJ
Biol Psychiatry; 2007 May; 61(10):1157-60. PubMed ID: 16950221
[TBL] [Abstract][Full Text] [Related]
3. The effects of guanfacine on working memory performance in patients with localization-related epilepsy and healthy controls.
Swartz BE; McDonald CR; Patel A; Torgersen D
Clin Neuropharmacol; 2008; 31(5):251-60. PubMed ID: 18836342
[TBL] [Abstract][Full Text] [Related]
4. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
Kisicki JC; Fiske K; Lyne A
Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
[TBL] [Abstract][Full Text] [Related]
5. Effect of ispronicline, a neuronal nicotinic acetylcholine receptor partial agonist, in subjects with age associated memory impairment (AAMI).
Dunbar GC; Inglis F; Kuchibhatla R; Sharma T; Tomlinson M; Wamsley J
J Psychopharmacol; 2007 Mar; 21(2):171-8. PubMed ID: 17329297
[TBL] [Abstract][Full Text] [Related]
6. Guanfacine in children with autism and/or intellectual disabilities.
Handen BL; Sahl R; Hardan AY
J Dev Behav Pediatr; 2008 Aug; 29(4):303-8. PubMed ID: 18552703
[TBL] [Abstract][Full Text] [Related]
7. Improving effects of huperzine A on spatial working memory in aged monkeys and young adult monkeys with experimental cognitive impairment.
Ye JW; Cai JX; Wang LM; Tang XC
J Pharmacol Exp Ther; 1999 Feb; 288(2):814-9. PubMed ID: 9918593
[TBL] [Abstract][Full Text] [Related]
8. No improvement of posttraumatic stress disorder symptoms with guanfacine treatment.
Neylan TC; Lenoci M; Samuelson KW; Metzler TJ; Henn-Haase C; Hierholzer RW; Lindley SE; Otte C; Schoenfeld FB; Yesavage JA; Marmar CR
Am J Psychiatry; 2006 Dec; 163(12):2186-8. PubMed ID: 17151174
[TBL] [Abstract][Full Text] [Related]
9. Age-associated memory impairment: diagnostic criteria and treatment strategies.
Crook T; Bahar H; Sudilovsky A
Int J Neurol; 1987-1988; 21-22():73-82. PubMed ID: 2980693
[TBL] [Abstract][Full Text] [Related]
10. [Memory complaints in 200 subjects meeting the diagnostic criteria for age-associated memory impairment: psychoaffective and cognitive correlates].
Derouesné C; Rapin JR; Lacomblez L
Psychol Neuropsychiatr Vieil; 2004 Mar; 2(1):67-74. PubMed ID: 15683970
[TBL] [Abstract][Full Text] [Related]
11. [Age-associated memory impairment].
Krzymiński S
Psychiatr Pol; 1995; 29(3):319-31. PubMed ID: 7652085
[TBL] [Abstract][Full Text] [Related]
12. Chinese herbal medicine for Mild Cognitive Impairment and Age Associated Memory Impairment: a review of randomised controlled trials.
May BH; Yang AW; Zhang AL; Owens MD; Bennett L; Head R; Cobiac L; Li CG; Hugel H; Story DF; Xue CC
Biogerontology; 2009 Apr; 10(2):109-23. PubMed ID: 18716893
[TBL] [Abstract][Full Text] [Related]
13. A randomized, placebo-controlled trial of citicoline add-on therapy in outpatients with bipolar disorder and cocaine dependence.
Brown ES; Gorman AR; Hynan LS
J Clin Psychopharmacol; 2007 Oct; 27(5):498-502. PubMed ID: 17873684
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled trial of donepezil to improve memory in epilepsy.
Hamberger MJ; Palmese CA; Scarmeas N; Weintraub D; Choi H; Hirsch LJ
Epilepsia; 2007 Jul; 48(7):1283-91. PubMed ID: 17484756
[TBL] [Abstract][Full Text] [Related]
15. Idazoxan blocks the nicotine-induced reversal of the memory impairment caused by the NMDA glutamate receptor antagonist dizocilpine.
Timofeeva OA; Levin ED
Pharmacol Biochem Behav; 2008 Sep; 90(3):372-81. PubMed ID: 18456310
[TBL] [Abstract][Full Text] [Related]
16. Histamine H1-receptor blockade in humans affects psychomotor performance but not memory.
van Ruitenbeek P; Vermeeren A; Riedel W
J Psychopharmacol; 2008 Aug; 22(6):663-72. PubMed ID: 18208925
[TBL] [Abstract][Full Text] [Related]
17. Sources of declarative memory impairment in bipolar disorder: mnemonic processes and clinical features.
Bearden CE; Glahn DC; Monkul ES; Barrett J; Najt P; Kaur S; Sanches M; Villarreal V; Bowden C; Soares JC
J Psychiatr Res; 2006 Feb; 40(1):47-58. PubMed ID: 16199055
[TBL] [Abstract][Full Text] [Related]
18. Depressed mood and memory impairment in temporal lobe epilepsy as a function of focus lateralization and localization.
Helmstaedter C; Sonntag-Dillender M; Hoppe C; Elger CE
Epilepsy Behav; 2004 Oct; 5(5):696-701. PubMed ID: 15380121
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin converting enzyme and memory: preclinical and clinical data.
Sudilovsky A; Turnbull B; Croog SH; Crook T
Int J Neurol; 1987-1988; 21-22():145-62. PubMed ID: 2856549
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects.
Kay G; Crook T; Rekeda L; Lima R; Ebinger U; Arguinzoniz M; Steel M
Eur Urol; 2006 Aug; 50(2):317-26. PubMed ID: 16687205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
